NN

Nagendra Nagasundar

Active Director Director DIN 07603669
DIN 07603669 First appointment May 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2017
Shareholding value •••• Premium profile

About Nagendra Nagasundar

Data last updated:

Nagendra Nagasundar is a Director at Nextbio Research Private Limited (since 2017). The company operates in Pharma. Nextbio Research Private Limited reported revenue of ₹23,809 (FY 2022).

DIN 07603669
Primary Designation Director
Industry Pharma
First Appointment 02 May 2017
Oldest Company Age 10 yrs
Largest company Nextbio Research Private Limited · ₹23,809 (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nextbio Research Private Limited U73100KA2016PTC095455
Director02 May 20172016₹23,809 (FY 2022)Active

Board colleagues of Nagendra Nagasundar

Directorship timeline

Open interactive timeline →
Nextbio Research Private Limited
Premium access

Shareholding and investment profile for Nagendra Nagasundar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nagendra Nagasundar

Nagendra Nagasundar currently holds 1 directorship: Nextbio Research Private Limited (Director, since 02 May 2017, revenue ₹23,809 (FY 2022)).

Nagendra Nagasundar was first appointed on 02 May 2017 as Director at Nextbio Research Private Limited.

The current boards of Nagendra Nagasundar's companies include Umesh Anantha Padmanabha Bisile (Nextbio Research Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available